Skip to main content
ConductScienceScienceDex

Hui-Kuan Lin

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #8,179
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9090324Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-3501-2410Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology
  • Pharmacology

NIH Funding · FY2026

Linked Award Amount
$2.4M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#8,179
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Hui-Kuan Lin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$2.4M

4 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Hui-Kuan Lin as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA299084-01A1R01Contact PI
    Identification and inhibition of the novel downstream effectors of mutant Ras for mutant Ras-driven cancer targeting
    Duke University · Pathology (NIH department code)
    $693.4K
    award amount
  • 5R01CA277682-05R01Co-investigator
    Drug Development of Skp2 PROTACs in Cancer
    UT Health Science Center Houston · Pharmacology (NIH department code)
    $643.3K
    award amount
  • 5R01CA256158-06R01Contact PI
    Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance
    Duke University · Pathology (NIH department code)
    $518.4K
    award amount
  • 5R01CA270617-05R01Contact PI
    Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer
    Duke University · Pathology (NIH department code)
    $506.9K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Hui-Kuan Lin as a PI.

Duke University
NC
$1.7M
3 grants
UT Health Science Center Houston
TX
$643.3K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Duke University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5116
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Hui-Kuan Lin.

Hong-Yu Li
UT Health Science Center Houston
3
shared awards
Hong-Yu Li
Duke University
1
shared award

Explore further

Find collaborators for Hui-Kuan Lin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →